These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25642325)

  • 1. Periprosthetic bone loss: diagnostic and therapeutic approaches.
    Cavalli L; Brandi ML
    F1000Res; 2013; 2():266. PubMed ID: 25642325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients.
    Soininvaara TA; Jurvelin JS; Miettinen HJ; Suomalainen OT; Alhava EM; Kröger PJ
    Calcif Tissue Int; 2002 Dec; 71(6):472-7. PubMed ID: 12370800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium in the bone-implant interface.
    Vestermark MT
    Dan Med Bull; 2011 May; 58(5):B4286. PubMed ID: 21535993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate treatment for osteolysis in total hip arthroplasty. A report of four cases.
    Trevisan C; Nava V; Mattavelli M; Parra CG
    Clin Cases Miner Bone Metab; 2013 Jan; 10(1):61-4. PubMed ID: 23858314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate improves implant osseointegration.
    Maïmoun L; Brennan TC; Badoud I; Dubois-Ferriere V; Rizzoli R; Ammann P
    Bone; 2010 May; 46(5):1436-41. PubMed ID: 20116464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wear and osteolysis in total joint replacements.
    Kadoya Y; Kobayashi A; Ohashi H
    Acta Orthop Scand Suppl; 1998 Feb; 278():1-16. PubMed ID: 9524528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VASCULARITY STUDY ON PERIPROSTHETIC TISSUES AROUND ASEPTIC LOOSENING AFTER TOTAL HIP ARTHROPLASTY].
    Wu W; Yan M; Zhu Z; Dai K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Jan; 30(1):39-43. PubMed ID: 27062844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprosthetic bone density as outcome of therapeutic response.
    Iolascon G; Di Pietro G; Capaldo A; Gioia C; Gatto S; Gimigliano F
    Clin Cases Miner Bone Metab; 2010 Jan; 7(1):27-31. PubMed ID: 22461288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss.
    Rahmy AI; Gosens T; Blake GM; Tonino A; Fogelman I
    Osteoporos Int; 2004 Apr; 15(4):281-9. PubMed ID: 14661072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle Disease: A Current Review of the Biological Mechanisms in Periprosthetic Osteolysis After Hip Arthroplasty.
    Sukur E; Akman YE; Ozturkmen Y; Kucukdurmaz F
    Open Orthop J; 2016; 10():241-51. PubMed ID: 27499822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine model of prosthesis failure for the long-term study of aseptic loosening.
    Yang SY; Yu H; Gong W; Wu B; Mayton L; Costello R; Wooley PH
    J Orthop Res; 2007 May; 25(5):603-11. PubMed ID: 17278141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there a bone-preserving bone remodelling in short-stem prosthesis? DEXA analysis with the Nanos total hip arthroplasty].
    Götze C; Ehrenbrink J; Ehrenbrink H
    Z Orthop Unfall; 2010 Aug; 148(4):398-405. PubMed ID: 20714981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone loss around a stable, partly threaded hydroxyapatite-coated cup: a prospective cohort study using RSA and DXA.
    Lazarinis S; Milbrink J; Mattsson P; Mallmin H; Hailer NP
    Hip Int; 2014; 24(2):155-66. PubMed ID: 24500826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry--a 3-year follow-up study.
    Venesmaa PK; Kröger HP; Miettinen HJ; Jurvelin JS; Suomalainen OT; Alhava EM
    J Bone Miner Res; 2001 Jun; 16(6):1056-61. PubMed ID: 11393782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of periprosthetic bone remodeling around stable uncemented tapered hip stems: a prospective 84-month follow-up study and a median 156-month cross-sectional study with DXA.
    Aldinger PR; Sabo D; Pritsch M; Thomsen M; Mau H; Ewerbeck V; Breusch SJ
    Calcif Tissue Int; 2003 Aug; 73(2):115-21. PubMed ID: 14565592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.
    Goulding KA; Schwartz A; Hattrup SJ; Randall RL; Lee D; Rispoli DM; Lerman DM; Beauchamp C
    Clin Orthop Relat Res; 2017 Jun; 475(6):1702-1711. PubMed ID: 28194713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
    Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
    Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles.
    Miyanishi K; Trindade MC; Ma T; Goodman SB; Schurman DJ; Smith RL
    J Bone Miner Res; 2003 Sep; 18(9):1573-83. PubMed ID: 12968666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conus hip prosthesis.
    Wagner H; Wagner M
    Acta Chir Orthop Traumatol Cech; 2001; 68(4):213-21. PubMed ID: 11706545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients.
    Jaroma AV; Soininvaara TA; Kröger H
    Bone Joint J; 2015 Mar; 97-B(3):337-45. PubMed ID: 25737517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.